ATE285782T1 - Pharmazeutische zusammensetzungen die ein alkylaryl polyether alkohol polymer enthalten - Google Patents

Pharmazeutische zusammensetzungen die ein alkylaryl polyether alkohol polymer enthalten

Info

Publication number: ATE285782T1
Authority: AT; Austria
Prior art keywords: pharmaceutical compositions; tyloxapol; compositions containing; active ingredient; agents
Prior art date: 1996-04-25

Application number

AT97922426T

Other languages

English (en)

Inventor

Thomas P Kennedy

Original Assignee

Charlotte Mecklenburg Hospital

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-04-25

Filing date

1997-04-23

Publication date

2005-01-15

1997-04-23 Application filed by Charlotte Mecklenburg Hospital filed Critical Charlotte Mecklenburg Hospital

2005-01-15 Application granted granted Critical

2005-01-15 Publication of ATE285782T1 publication Critical patent/ATE285782T1/de

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title 1
239000004721 Polyphenylene oxide Substances 0.000 title 1
229920000570 polyether Polymers 0.000 title 1
229920000642 polymer Polymers 0.000 title 1
239000004480 active ingredient Substances 0.000 abstract 4
MDYZKJNTKZIUSK-UHFFFAOYSA-N tyloxapol Chemical compound O=C.C1CO1.CC(C)(C)CC(C)(C)C1=CC=C(O)C=C1 MDYZKJNTKZIUSK-UHFFFAOYSA-N 0.000 abstract 4
229960004224 tyloxapol Drugs 0.000 abstract 4
229920001664 tyloxapol Polymers 0.000 abstract 4
239000003795 chemical substances by application Substances 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 3
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
238000009472 formulation Methods 0.000 abstract 2
KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 abstract 1
208000009079 Bronchial Spasm Diseases 0.000 abstract 1
206010020852 Hypertonia Diseases 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
150000003904 phospholipids Chemical class 0.000 abstract 1
229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
230000001988 toxicity Effects 0.000 abstract 1
231100000419 toxicity Toxicity 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Pulmonology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Otolaryngology (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

AT97922426T 1996-04-25 1997-04-23 Pharmazeutische zusammensetzungen die ein alkylaryl polyether alkohol polymer enthalten ATE285782T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/638,893 US5849263A (en)	1993-03-30	1996-04-25	Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
PCT/US1997/006862 WO1997039758A1 (en)	1996-04-25	1997-04-23	Pharmaceutical compositions containing alkylaryl polyether alcohol polymer

Publications (1)

Publication Number	Publication Date
ATE285782T1 true ATE285782T1 (de)	2005-01-15

Family

ID=24561894

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97922426T ATE285782T1 (de)	1996-04-25	1997-04-23	Pharmazeutische zusammensetzungen die ein alkylaryl polyether alkohol polymer enthalten

Country Status (9)

Country	Link
US (2)	US5849263A (de)
EP (1)	EP0910390B1 (de)
JP (1)	JP2001504438A (de)
AT (1)	ATE285782T1 (de)
AU (1)	AU2809697A (de)
CA (1)	CA2251656C (de)
DE (1)	DE69732109T2 (de)
ES (1)	ES2234017T3 (de)
WO (1)	WO1997039758A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5849263A (en) *	1993-03-30	1998-12-15	Charlotte-Mecklenburg Hospital Authority	Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
US6939859B1 (en) *	1999-03-31	2005-09-06	Cci Corp.	Skin preparations for external use
US6240313B1 (en) *	1999-04-19	2001-05-29	Cardiac Pacemakers, Inc.	Cardiac rhythm management system with prevention of double counting of events
GB0008660D0 (en)	2000-04-07	2000-05-31	Arakis Ltd	The treatment of respiratory diseases
US20030053956A1 (en) *	2001-01-24	2003-03-20	Thomas Hofmann	Alkylaryl polyether alcohol polymers for treatment and prophylaxis of snoring, sleep apnea, sudden infant death syndrome and for improvement of nasal breathing
US8815258B2 (en)	2009-05-29	2014-08-26	Pearl Therapeutics, Inc.	Compositions, methods and systems for respiratory delivery of two or more active agents
PL3111927T3 (pl)	2009-05-29	2020-06-29	Pearl Therapeutics, Inc.	Kompozycje do wziewnego podawania środków aktywnych oraz związane z nimi sposoby i systemy
SG11201507286QA (en)	2013-03-15	2015-10-29	Pearl Therapeutics Inc	Methods and systems for conditioning of particulate crystalline materials

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2454541A (en) *	1944-09-09	1948-11-23	Rohm & Haas	Polymeric detergents
US3272700A (en) *	1963-10-03	1966-09-13	Sterling Drug Inc	Stabilized aqueous solution of tetracaine salt
DE1929039C3 (de) *	1968-06-12	1974-08-15	Konishiroku Photo Industry Co., Ltd., Tokio	Lichtempfindliche fotografische Silberhalogenidemulsion
US4039669A (en) *	1975-08-01	1977-08-02	Sterling Drug Inc.	Composition for topical application and use thereof
US5110806A (en) *	1985-06-26	1992-05-05	The Regents Of The University Of California	Lung surfactant compositions
US4826821A (en) *	1985-06-26	1989-05-02	The Regents Of The University Of California	Lung surfactant compositions
US4944941A (en) *	1987-08-07	1990-07-31	Genentech, Inc.	Methods and compositions for the treatment of lung conditions
US5259963A (en) *	1989-01-12	1993-11-09	Sandoz Ltd.	Surface active compositions their production and use
US5134129A (en) *	1989-03-15	1992-07-28	Board Of Regents, The University Of Texas System	Methods employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
US5399363A (en) *	1991-01-25	1995-03-21	Eastman Kodak Company	Surface modified anticancer nanoparticles
US5145684A (en) *	1991-01-25	1992-09-08	Sterling Drug Inc.	Surface modified drug nanoparticles
ES2097282T3 (es) *	1992-05-26	1997-04-01	Procter & Gamble	Composiciones farmaceuticas para uso como estabilizador de mastocitos.
US5362758A (en) *	1992-09-18	1994-11-08	Pfizer Inc.	Ophthalmic piroxicam solution
US5840277A (en) *	1993-03-30	1998-11-24	Charlotte Hospital Authority	Treatment of chronic pulmonary inflammation
CA2102142A1 (en) *	1993-03-30	1994-10-01	Andrew J. Ghio	Method of inhibiting oxidants using alkylaryl polyether alcohol polymers
US5830436A (en) *	1993-03-30	1998-11-03	Duke University	Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
US5849263A (en) *	1993-03-30	1998-12-15	Charlotte-Mecklenburg Hospital Authority	Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
US5540930A (en) *	1993-10-25	1996-07-30	Pharmos Corporation	Suspension of loteprednol etabonate for ear, eye, or nose treatment
US5576311A (en) *	1994-11-30	1996-11-19	Pharmos Corporation	Cyclodextrins as suspending agents for pharmaceutical suspensions
US5747001A (en) *	1995-02-24	1998-05-05	Nanosystems, L.L.C.	Aerosols containing beclomethazone nanoparticle dispersions
US5770585A (en) *	1995-05-08	1998-06-23	Kaufman; Robert J.	Homogeneous water-in-perfluorochemical stable liquid dispersion for administration of a drug to the lung of an animal
EP0780127A1 (de) *	1995-12-19	1997-06-25	The Procter & Gamble Company	Nasenspray enthaltend einen Steroid und einen Antihistamin
US6037328A (en) *	1998-12-22	2000-03-14	Bausch & Lomb Incorporated	Method and composition for rewetting and preventing deposits on contact lens

1996
- 1996-04-25 US US08/638,893 patent/US5849263A/en not_active Expired - Lifetime
1997
- 1997-04-23 AT AT97922426T patent/ATE285782T1/de not_active IP Right Cessation
- 1997-04-23 EP EP97922426A patent/EP0910390B1/de not_active Expired - Lifetime
- 1997-04-23 CA CA002251656A patent/CA2251656C/en not_active Expired - Fee Related
- 1997-04-23 JP JP53833297A patent/JP2001504438A/ja active Pending
- 1997-04-23 AU AU28096/97A patent/AU2809697A/en not_active Abandoned
- 1997-04-23 DE DE69732109T patent/DE69732109T2/de not_active Expired - Lifetime
- 1997-04-23 WO PCT/US1997/006862 patent/WO1997039758A1/en not_active Ceased
- 1997-04-23 ES ES97922426T patent/ES2234017T3/es not_active Expired - Lifetime
1998
- 1998-12-11 US US09/210,032 patent/US6165445A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US5849263A (en)	1998-12-15
EP0910390B1 (de)	2004-12-29
EP0910390A1 (de)	1999-04-28
WO1997039758A1 (en)	1997-10-30
DE69732109D1 (de)	2005-02-03
CA2251656A1 (en)	1997-10-30
US6165445A (en)	2000-12-26
AU2809697A (en)	1997-11-12
DE69732109T2 (de)	2005-12-22
JP2001504438A (ja)	2001-04-03
CA2251656C (en)	2008-07-08
ES2234017T3 (es)	2005-06-16

Legal Events

Date

Code

Title

Description

2005-08-15

UEP

Publication of translation of european patent specification

Ref document number: 0910390

Country of ref document: EP

2011-01-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
CA2203033A1 (en)	1996-05-02	Compounds and compositions for delivering active agents
CA2133177A1 (en)	1995-03-31	Rapamycin formulations for oral administration
CA2031572A1 (en)	1991-10-01	Non-alcoholic delivery system for orally ingestible active ingredients
IL117889A0 (en)	1996-08-04	Pharmaceutical compositions containing lipophilic compounds
NZ318282A (en)	2000-01-28	Pharmaceutical formulation containing amoxycillin and clavulanate in a weight ratio of 12:1 and 20:1
MY111260A (en)	1999-10-30	Pharmaceutical composition for the treatment of nicotine dependence
DE3669106D1 (de)	1990-04-05	Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
FI955403A0 (fi)	1995-11-09	Valeltavia koostumuksia, jotka sisältävät polymeerimateriaalia, glykoleja ja glyseridejä
DE69430070D1 (de)	2002-04-11	Topische pharmazeutische zusammensetzungen die (s)-2-(4-isobutylphenyl) propionsaeure enthalten
DE69732109D1 (de)	2005-02-03	Pharmazeutische zusammensetzungen die ein alkylaryl polyether alkohol polymer enthalten
IT1272149B (it)	1997-06-11	Composizione farmeceutiche ad attivita' analgesica
KR950007857A (ko)	1995-04-15	경구투여용 라파마이신 제제
HUP9902415A2 (hu)	1999-11-29	Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
EE9700102A (et)	1997-10-15	Selegiliini sisaldav liposoomne kompositsioon
IT1250672B (it)	1995-04-21	Formulazioni orali di ubidecarenone in soluzione acquosa
ATE173624T1 (de)	1998-12-15	Synergistische pharmazeutische zusammensetungen, die triamcinolonacetonid und halcinonid enthalten
SE9403389D0 (sv)	1994-10-06	Pharmaceutical composition containing derivattves of sex hormones
EP0356264A3 (de)	1991-03-06	Reiningungsmittel für die örtliche Desinfektion
JP2000319171A (ja)	2000-11-21	殺菌性皮膚外用剤組成物
FR2604903B1 (fr)	1989-01-13	Agents therapeutiques sous forme de particules submicroscopiques contre des parasitoses et compositions pharmaceutiques les contenant
EP0558721B1 (de)	1995-11-29	Reichstoffzusammensetzungen
EP0056681A3 (de)	1983-07-20	Formulierungen des Levonantradols und N-Methyllevonantradols
HK1039275A1 (zh)	2002-04-19	含有二甲聚硅氧烷的阿昔洛韋組合物
ATE223700T1 (de)	2002-09-15	Ramoplaninhaltige neue injizierbare arzneizubereitungen
EP1100446B1 (de)	2004-04-07	Deodorant enthaltend kräuterwirkstoffe